Transdigm Group INC Form 4 insider transactions

TransDigm Group's Co-Chief Operating Officer, Patrick Joseph Murphy, exercised stock options and subsequently sold 580 shares of common stock under a Rule 10b5-1 plan.

TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and subsequently sold an equivalent number of shares under a pre-arranged 10b5-1 plan.

TransDigm Group Director W. Nicholas Howley exercised stock options and simultaneously sold an equal number of common shares under a Rule 10b5-1 plan.

TransDigm Group Co-Chief Operating Officer Joel Reiss exercised stock options and subsequently sold 3,000 shares of common stock under a pre-arranged 10b5-1 plan.

TransDigm Group director Robert J. Small filed an amended Form 4 to correct the reported amount of common stock directly owned.

TransDigm Group Director Michele Santana acquired 29 shares of common stock, valued at $1,288.13 per share, as part of her semi-annual director fee.

TransDigm Group Director Sean P. Hennessy acquired 36 shares of common stock as part of his semi-annual director fee.

TransDigm Group Director Michael Graff acquired 29 shares of common stock valued at $1,288.13 per share as part of his semi-annual director fee.

TransDigm Director Jane M. Cronin acquires 29 shares for fee.

TransDigm Group Director David Barr acquired 36 shares of common stock on September 19, 2025, as part of his semi-annual director fee, bringing his total beneficial ownership to 32,138 shares.

TransDigm Group Director Robert J. Small acquired 44 shares of common stock on September 19, 2025, as part of his semi-annual director compensation.

TransDigm Group director W. Nicholas Howley exercised stock options and subsequently sold 2,736 shares of common stock through a 10b5-1 plan.

TransDigm Group Director Robert J. Small reported significant sales of company common stock by entities he manages and a personal gift of shares.

TransDigm Group Director Robert J. Small reported a distribution of 2,318 common shares from Stockbridge Fund, L.P. to its partners.

TransDigm Group Director Michael Graff exercised stock options and subsequently sold an equal number of shares for approximately $1,400 per share.

TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and subsequently sold a portion of his common stock holdings under a Rule 10b5-1 plan.

TransDigm Group Director W. Nicholas Howley exercised stock options and subsequently sold an equivalent number of shares for liquidity and diversification.

TransDigm Group INC's Co-Chief Operating Officer, Joel Reiss, exercised stock options and subsequently sold 3,000 shares of common stock on July 21, 2025, as part of a pre-arranged trading plan.

W. Nicholas Howley, a Director at TransDigm Group INC, executed a series of pre-planned transactions on July 15, 2025, involving the exercise of stock options and subsequent sale of common stock.

TransDigm Group INC's Co-Chief Operating Officer, Joel Reiss, significantly reduced his direct beneficial ownership by 3,000 shares on June 20, 2025, through a series of sales after exercising stock options.

TransDigm Group INC Director W. Nicholas Howley exercised stock options and subsequently sold a portion of the underlying common stock through a Rule 10b5-1 plan.

TransDigm Group Inc.'s Chief Financial Officer, Sarah Wynne, completed a pre-scheduled transaction on June 13, 2025, involving the exercise of stock options and the subsequent sale of common shares under a Rule 10b5-1 plan.

TransDigm Group INC Director Michael Graff reported a re-allocation of 1,000 common shares from direct ownership to family trusts, as disclosed in a recent SEC Form 4 filing.

TransDigm Group Inc. Director Robert J. Small reported the sale of 45,700 shares of common stock for approximately $65.1 million, executed under a Rule 10b5-1 trading plan.

TransDigm Group Inc.'s Chief Financial Officer, Sarah Wynne, reported the exercise of stock options and subsequent sale of common stock on June 12, 2025, under a pre-arranged 10b5-1 trading plan.

Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on May 20, 2025, according to a Form 4 filing.

Director Sean Hennessy exercised stock options and sold shares of TransDigm Group INC on May 20, 2025.

Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on May 15, 2025, according to a Form 4 filing with the SEC.

Director Michael Graff reports changes in beneficial ownership of TransDigm Group INC stock due to trust transactions.

Director Jorge L. Valladares III exercised stock options and sold shares of TransDigm Group INC through a family trust on May 13 and 14, 2025.